Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Celiac Disease | 116 | 2024 | 820 | 20.070 |
Why?
|
Glutens | 49 | 2022 | 240 | 9.730 |
Why?
|
Haptoglobins | 40 | 2024 | 166 | 7.510 |
Why?
|
Diet, Gluten-Free | 39 | 2022 | 285 | 6.360 |
Why?
|
Intestinal Mucosa | 61 | 2023 | 3046 | 5.910 |
Why?
|
Protein Precursors | 38 | 2024 | 1134 | 5.750 |
Why?
|
Cholera Toxin | 35 | 2020 | 563 | 4.800 |
Why?
|
Tight Junctions | 29 | 2023 | 330 | 3.990 |
Why?
|
Gliadin | 29 | 2023 | 80 | 3.760 |
Why?
|
Permeability | 39 | 2022 | 726 | 3.510 |
Why?
|
Duodenum | 14 | 2022 | 495 | 2.800 |
Why?
|
Transglutaminases | 19 | 2023 | 201 | 2.720 |
Why?
|
Oligopeptides | 12 | 2021 | 1192 | 2.130 |
Why?
|
Intestine, Small | 16 | 2019 | 1214 | 1.940 |
Why?
|
Autoimmune Diseases | 18 | 2021 | 2226 | 1.840 |
Why?
|
Probiotics | 8 | 2024 | 387 | 1.830 |
Why?
|
Intestinal Diseases | 6 | 2024 | 506 | 1.630 |
Why?
|
Intestines | 19 | 2023 | 1906 | 1.560 |
Why?
|
Gastrointestinal Tract | 12 | 2022 | 834 | 1.480 |
Why?
|
Intestinal Absorption | 11 | 2019 | 399 | 1.470 |
Why?
|
Immunoglobulin A | 19 | 2024 | 995 | 1.470 |
Why?
|
Gastrointestinal Diseases | 8 | 2021 | 1203 | 1.270 |
Why?
|
Autoimmunity | 10 | 2021 | 1354 | 1.230 |
Why?
|
Systemic Inflammatory Response Syndrome | 9 | 2024 | 622 | 1.190 |
Why?
|
Food Hypersensitivity | 7 | 2020 | 737 | 1.150 |
Why?
|
Irritable Bowel Syndrome | 7 | 2020 | 454 | 1.100 |
Why?
|
Salmonella typhi | 6 | 2024 | 201 | 1.050 |
Why?
|
Inflammatory Bowel Diseases | 6 | 2024 | 2429 | 0.980 |
Why?
|
Autoantibodies | 18 | 2023 | 2113 | 0.980 |
Why?
|
Colostrum | 1 | 2023 | 28 | 0.870 |
Why?
|
Inflammation | 22 | 2023 | 10850 | 0.840 |
Why?
|
Humans | 250 | 2024 | 765968 | 0.840 |
Why?
|
Blood-Brain Barrier | 6 | 2022 | 1037 | 0.820 |
Why?
|
Factor X | 1 | 2022 | 64 | 0.820 |
Why?
|
Enterocolitis, Necrotizing | 2 | 2016 | 328 | 0.790 |
Why?
|
Diabetes Mellitus, Type 1 | 6 | 2023 | 3446 | 0.790 |
Why?
|
Shigella flexneri | 4 | 2019 | 118 | 0.780 |
Why?
|
Typhoid Fever | 5 | 2024 | 197 | 0.780 |
Why?
|
Serologic Tests | 8 | 2019 | 382 | 0.780 |
Why?
|
GTP-Binding Proteins | 4 | 2017 | 945 | 0.770 |
Why?
|
Diet | 10 | 2024 | 8086 | 0.750 |
Why?
|
Cytokines | 19 | 2024 | 7421 | 0.740 |
Why?
|
Gastrointestinal Transit | 1 | 2021 | 102 | 0.710 |
Why?
|
HLA Antigens | 6 | 2019 | 1339 | 0.710 |
Why?
|
Gastric Emptying | 2 | 2021 | 247 | 0.680 |
Why?
|
HLA-DQ Antigens | 9 | 2020 | 190 | 0.680 |
Why?
|
Child | 70 | 2024 | 80564 | 0.670 |
Why?
|
Addison Disease | 1 | 2020 | 48 | 0.650 |
Why?
|
Dermatitis Herpetiformis | 5 | 2014 | 23 | 0.630 |
Why?
|
Intercellular Junctions | 1 | 2019 | 198 | 0.620 |
Why?
|
Metagenome | 2 | 2013 | 464 | 0.620 |
Why?
|
Metabolome | 7 | 2023 | 1005 | 0.620 |
Why?
|
Receptors, CXCR3 | 2 | 2010 | 240 | 0.600 |
Why?
|
Caco-2 Cells | 12 | 2022 | 366 | 0.600 |
Why?
|
Cell Membrane Permeability | 4 | 2011 | 562 | 0.590 |
Why?
|
Wheat Hypersensitivity | 3 | 2018 | 11 | 0.580 |
Why?
|
Biopsy | 15 | 2022 | 6763 | 0.560 |
Why?
|
Immunity, Mucosal | 6 | 2024 | 498 | 0.560 |
Why?
|
Infant | 37 | 2024 | 36386 | 0.550 |
Why?
|
Breast Feeding | 5 | 2019 | 1364 | 0.550 |
Why?
|
Peptides | 5 | 2021 | 4331 | 0.550 |
Why?
|
Interleukin-8 | 5 | 2019 | 700 | 0.540 |
Why?
|
Immunoglobulin G | 17 | 2024 | 4528 | 0.540 |
Why?
|
Hypersensitivity | 3 | 2016 | 1168 | 0.530 |
Why?
|
Vomiting | 1 | 2020 | 647 | 0.530 |
Why?
|
Antibodies, Anti-Idiotypic | 3 | 2020 | 340 | 0.520 |
Why?
|
Milk, Human | 4 | 2024 | 490 | 0.520 |
Why?
|
Diarrhea | 11 | 2020 | 1316 | 0.490 |
Why?
|
Antibodies, Viral | 10 | 2024 | 3211 | 0.490 |
Why?
|
Bone Morphogenetic Protein 4 | 1 | 2015 | 163 | 0.490 |
Why?
|
Animals | 68 | 2023 | 168764 | 0.480 |
Why?
|
Metabolomics | 7 | 2022 | 1668 | 0.480 |
Why?
|
Receptors, Formyl Peptide | 1 | 2015 | 146 | 0.480 |
Why?
|
Antibodies | 9 | 2019 | 2417 | 0.470 |
Why?
|
Chickens | 1 | 2016 | 842 | 0.470 |
Why?
|
Schizophrenia | 11 | 2020 | 6972 | 0.460 |
Why?
|
Gastrointestinal Agents | 1 | 2019 | 510 | 0.460 |
Why?
|
Shigella dysenteriae | 1 | 2014 | 14 | 0.450 |
Why?
|
DNA, Bacterial | 1 | 2019 | 1477 | 0.450 |
Why?
|
Epithelial Cells | 11 | 2021 | 3681 | 0.450 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 2016 | 239 | 0.440 |
Why?
|
Interleukin-10 | 2 | 2020 | 1183 | 0.440 |
Why?
|
Lactobacillus | 2 | 2019 | 213 | 0.440 |
Why?
|
Genetic Predisposition to Disease | 15 | 2024 | 18071 | 0.440 |
Why?
|
Automation, Laboratory | 1 | 2014 | 102 | 0.430 |
Why?
|
Receptor, PAR-2 | 2 | 2010 | 34 | 0.430 |
Why?
|
Antiviral Agents | 4 | 2023 | 3050 | 0.430 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2016 | 339 | 0.420 |
Why?
|
Food Contamination | 2 | 2013 | 194 | 0.420 |
Why?
|
Pregnancy Complications, Infectious | 5 | 2024 | 2187 | 0.420 |
Why?
|
Bacteria | 6 | 2020 | 2209 | 0.410 |
Why?
|
Feeding Methods | 2 | 2017 | 35 | 0.410 |
Why?
|
Abdominal Pain | 2 | 2018 | 1069 | 0.410 |
Why?
|
Child, Preschool | 35 | 2024 | 42500 | 0.400 |
Why?
|
Infant, Newborn | 25 | 2024 | 26346 | 0.400 |
Why?
|
Malabsorption Syndromes | 3 | 2018 | 135 | 0.390 |
Why?
|
Food | 3 | 2020 | 764 | 0.390 |
Why?
|
Hospitals, General | 1 | 2016 | 802 | 0.380 |
Why?
|
Down-Regulation | 2 | 2017 | 2927 | 0.380 |
Why?
|
Enterobacteriaceae | 3 | 2021 | 161 | 0.380 |
Why?
|
Female | 96 | 2024 | 396112 | 0.380 |
Why?
|
Endoscopy, Gastrointestinal | 2 | 2017 | 888 | 0.380 |
Why?
|
Peptide Hydrolases | 3 | 2018 | 608 | 0.370 |
Why?
|
Sequence Analysis, RNA | 1 | 2019 | 2034 | 0.370 |
Why?
|
Hedgehog Proteins | 1 | 2015 | 774 | 0.360 |
Why?
|
Hypersensitivity, Delayed | 1 | 2012 | 490 | 0.360 |
Why?
|
Colitis | 2 | 2017 | 1239 | 0.360 |
Why?
|
Male | 88 | 2024 | 363698 | 0.350 |
Why?
|
Immunity | 6 | 2024 | 1002 | 0.350 |
Why?
|
Infant Nutritional Physiological Phenomena | 2 | 2017 | 352 | 0.350 |
Why?
|
Immunoassay | 1 | 2014 | 741 | 0.350 |
Why?
|
Case-Control Studies | 18 | 2022 | 22223 | 0.340 |
Why?
|
Autistic Disorder | 2 | 2017 | 1239 | 0.340 |
Why?
|
Critical Illness | 2 | 2022 | 2744 | 0.340 |
Why?
|
Monitoring, Physiologic | 1 | 2017 | 1792 | 0.330 |
Why?
|
Stomach | 2 | 2018 | 699 | 0.330 |
Why?
|
Allergens | 2 | 2015 | 1436 | 0.330 |
Why?
|
Child Development | 5 | 2018 | 2327 | 0.330 |
Why?
|
Metagenomics | 4 | 2021 | 473 | 0.330 |
Why?
|
Obesity | 4 | 2023 | 13076 | 0.320 |
Why?
|
Forkhead Transcription Factors | 1 | 2017 | 1624 | 0.320 |
Why?
|
Immunity, Innate | 6 | 2019 | 3081 | 0.320 |
Why?
|
Helicobacter pylori | 1 | 2013 | 380 | 0.320 |
Why?
|
Cerebellum | 1 | 2016 | 1518 | 0.320 |
Why?
|
Adolescent | 35 | 2023 | 88835 | 0.320 |
Why?
|
Thyroid Nodule | 1 | 2016 | 779 | 0.310 |
Why?
|
Host-Pathogen Interactions | 2 | 2016 | 1461 | 0.310 |
Why?
|
Myosins | 1 | 2010 | 408 | 0.310 |
Why?
|
Diagnosis, Differential | 9 | 2020 | 12976 | 0.300 |
Why?
|
Interferon-gamma | 1 | 2017 | 3160 | 0.300 |
Why?
|
RNA, Ribosomal, 16S | 5 | 2023 | 1043 | 0.300 |
Why?
|
Neutrophils | 3 | 2022 | 3776 | 0.300 |
Why?
|
Interleukin-17 | 3 | 2019 | 921 | 0.300 |
Why?
|
Child Development Disorders, Pervasive | 4 | 2013 | 597 | 0.300 |
Why?
|
Triticum | 4 | 2018 | 92 | 0.290 |
Why?
|
Antibody Formation | 2 | 2022 | 1391 | 0.290 |
Why?
|
Culture Media, Conditioned | 1 | 2009 | 522 | 0.290 |
Why?
|
Mice, Transgenic | 7 | 2023 | 9550 | 0.290 |
Why?
|
Sepsis | 1 | 2021 | 2606 | 0.280 |
Why?
|
Molecular Targeted Therapy | 1 | 2018 | 2822 | 0.280 |
Why?
|
Pituitary Gland | 1 | 2010 | 631 | 0.280 |
Why?
|
Endothelial Cells | 3 | 2016 | 3584 | 0.270 |
Why?
|
Combined Modality Therapy | 1 | 2018 | 8529 | 0.270 |
Why?
|
Fatty Liver | 1 | 2013 | 807 | 0.270 |
Why?
|
Young Adult | 24 | 2023 | 59889 | 0.260 |
Why?
|
Leukocytes, Mononuclear | 5 | 2024 | 1857 | 0.260 |
Why?
|
Consensus Development Conferences, NIH as Topic | 1 | 2005 | 29 | 0.260 |
Why?
|
Environment | 3 | 2020 | 1114 | 0.260 |
Why?
|
Mice, Inbred C57BL | 16 | 2023 | 22332 | 0.250 |
Why?
|
Patient Compliance | 3 | 2013 | 2692 | 0.250 |
Why?
|
Phosphoproteins | 4 | 2020 | 2446 | 0.250 |
Why?
|
Specimen Handling | 2 | 2020 | 704 | 0.250 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2019 | 2310 | 0.250 |
Why?
|
Pregnancy | 15 | 2024 | 30260 | 0.250 |
Why?
|
Myocarditis | 2 | 2023 | 802 | 0.240 |
Why?
|
Feeding Behavior | 2 | 2015 | 3212 | 0.240 |
Why?
|
Lipopolysaccharides | 6 | 2021 | 2216 | 0.240 |
Why?
|
Mice | 30 | 2023 | 81819 | 0.240 |
Why?
|
Bacterial Translocation | 3 | 2020 | 74 | 0.240 |
Why?
|
Feces | 7 | 2022 | 1504 | 0.240 |
Why?
|
Endotoxins | 11 | 2010 | 516 | 0.240 |
Why?
|
Escherichia coli | 4 | 2019 | 4214 | 0.240 |
Why?
|
Psychotic Disorders | 5 | 2019 | 3270 | 0.230 |
Why?
|
Cell Movement | 2 | 2019 | 5194 | 0.230 |
Why?
|
Adult | 45 | 2024 | 223044 | 0.230 |
Why?
|
Wound Healing | 1 | 2015 | 2792 | 0.230 |
Why?
|
Adaptive Immunity | 3 | 2021 | 734 | 0.230 |
Why?
|
Dysentery, Bacillary | 2 | 2016 | 73 | 0.230 |
Why?
|
Organoids | 2 | 2021 | 739 | 0.220 |
Why?
|
Genetic Testing | 3 | 2014 | 3595 | 0.220 |
Why?
|
Shigella Vaccines | 2 | 2014 | 10 | 0.220 |
Why?
|
Immunoglobulin A, Secretory | 1 | 2023 | 105 | 0.220 |
Why?
|
Nutrition Assessment | 2 | 2024 | 738 | 0.220 |
Why?
|
Body Height | 1 | 2010 | 1562 | 0.220 |
Why?
|
Environmental Exposure | 2 | 2024 | 4544 | 0.220 |
Why?
|
Viral Load | 3 | 2021 | 3386 | 0.210 |
Why?
|
Biological Warfare | 1 | 2003 | 24 | 0.210 |
Why?
|
Epigenesis, Genetic | 1 | 2017 | 3819 | 0.210 |
Why?
|
Organ Culture Techniques | 5 | 2019 | 788 | 0.210 |
Why?
|
Toll-Like Receptor 4 | 5 | 2020 | 586 | 0.210 |
Why?
|
Claudins | 3 | 2016 | 118 | 0.210 |
Why?
|
Receptor, Cannabinoid, CB2 | 2 | 2013 | 48 | 0.210 |
Why?
|
Anti-Bacterial Agents | 6 | 2024 | 7478 | 0.210 |
Why?
|
Helminths | 1 | 2023 | 39 | 0.210 |
Why?
|
Budesonide | 2 | 2022 | 163 | 0.210 |
Why?
|
Synbiotics | 1 | 2022 | 12 | 0.210 |
Why?
|
Comorbidity | 9 | 2024 | 10563 | 0.200 |
Why?
|
Haplotypes | 5 | 2020 | 2728 | 0.200 |
Why?
|
Risk Factors | 17 | 2020 | 74840 | 0.200 |
Why?
|
Prospective Studies | 20 | 2023 | 54802 | 0.200 |
Why?
|
Bacteroides | 2 | 2020 | 165 | 0.200 |
Why?
|
Mass Screening | 3 | 2009 | 5446 | 0.200 |
Why?
|
Bioterrorism | 1 | 2003 | 144 | 0.200 |
Why?
|
Predictive Value of Tests | 7 | 2020 | 15398 | 0.200 |
Why?
|
Helminthiasis | 1 | 2023 | 81 | 0.200 |
Why?
|
Amino Acid Sequence | 6 | 2015 | 13400 | 0.190 |
Why?
|
Bacterial Toxins | 2 | 2005 | 924 | 0.190 |
Why?
|
Terminology as Topic | 3 | 2015 | 1534 | 0.190 |
Why?
|
Osteoporosis | 2 | 2012 | 1582 | 0.190 |
Why?
|
Bifidobacterium | 2 | 2019 | 99 | 0.190 |
Why?
|
Prevalence | 11 | 2019 | 15842 | 0.190 |
Why?
|
Typhoid-Paratyphoid Vaccines | 2 | 2018 | 40 | 0.190 |
Why?
|
Anorexia Nervosa | 2 | 2021 | 1328 | 0.190 |
Why?
|
Nasopharynx | 1 | 2024 | 419 | 0.190 |
Why?
|
Vero Cells | 1 | 2022 | 481 | 0.190 |
Why?
|
Cell Line | 8 | 2021 | 15543 | 0.180 |
Why?
|
Gastric Mucosa | 2 | 2021 | 602 | 0.180 |
Why?
|
Viral Nonstructural Proteins | 1 | 2022 | 226 | 0.180 |
Why?
|
Blood Cells | 1 | 2023 | 307 | 0.180 |
Why?
|
Gene Expression Regulation | 5 | 2020 | 11888 | 0.180 |
Why?
|
Glomerulonephritis, IGA | 1 | 2021 | 62 | 0.180 |
Why?
|
Interleukin-1beta | 5 | 2019 | 1028 | 0.180 |
Why?
|
Radiation Injuries, Experimental | 2 | 2016 | 88 | 0.180 |
Why?
|
Membrane Proteins | 7 | 2017 | 7851 | 0.180 |
Why?
|
Complementarity Determining Regions | 1 | 2021 | 154 | 0.180 |
Why?
|
Cerebral Cortex | 1 | 2016 | 5767 | 0.170 |
Why?
|
Herpesvirus 3, Human | 1 | 2021 | 159 | 0.170 |
Why?
|
Molecular Sequence Data | 5 | 2015 | 17594 | 0.170 |
Why?
|
Kynurenic Acid | 1 | 2020 | 44 | 0.170 |
Why?
|
Viral Matrix Proteins | 1 | 2021 | 192 | 0.170 |
Why?
|
Immunity, Maternally-Acquired | 1 | 2020 | 112 | 0.170 |
Why?
|
Pilot Projects | 8 | 2021 | 8733 | 0.170 |
Why?
|
Immunologic Tests | 1 | 2020 | 101 | 0.170 |
Why?
|
Salmonella paratyphi B | 1 | 2019 | 2 | 0.170 |
Why?
|
Saliva | 1 | 2024 | 851 | 0.170 |
Why?
|
Diarrhea, Infantile | 2 | 2019 | 100 | 0.170 |
Why?
|
Longitudinal Studies | 7 | 2021 | 14751 | 0.170 |
Why?
|
Monocytes | 6 | 2022 | 2595 | 0.170 |
Why?
|
Periodontal Diseases | 1 | 2023 | 453 | 0.160 |
Why?
|
Bacterial Adhesion | 2 | 2019 | 306 | 0.160 |
Why?
|
Chromosome Disorders | 1 | 2022 | 498 | 0.160 |
Why?
|
Stem Cells | 4 | 2019 | 3540 | 0.160 |
Why?
|
Cell Differentiation | 6 | 2023 | 11641 | 0.160 |
Why?
|
Growth Disorders | 1 | 2004 | 633 | 0.160 |
Why?
|
Gastroenterology | 4 | 2016 | 594 | 0.160 |
Why?
|
Salmonella paratyphi A | 1 | 2019 | 47 | 0.160 |
Why?
|
Hematologic Tests | 1 | 2020 | 239 | 0.160 |
Why?
|
Pancrelipase | 1 | 2018 | 7 | 0.160 |
Why?
|
Enterobacteriaceae Infections | 1 | 2021 | 189 | 0.160 |
Why?
|
Drug Repositioning | 1 | 2021 | 246 | 0.160 |
Why?
|
Treatment Failure | 2 | 2017 | 2652 | 0.160 |
Why?
|
Flagellin | 1 | 2019 | 124 | 0.160 |
Why?
|
Catalytic Domain | 1 | 2021 | 699 | 0.160 |
Why?
|
Protease Inhibitors | 1 | 2022 | 746 | 0.160 |
Why?
|
Mendelian Randomization Analysis | 1 | 2024 | 1044 | 0.160 |
Why?
|
Lactococcus lactis | 1 | 2018 | 28 | 0.160 |
Why?
|
Serine Endopeptidases | 3 | 2020 | 1024 | 0.150 |
Why?
|
Cattle | 2 | 2023 | 3801 | 0.150 |
Why?
|
Signal Transduction | 11 | 2020 | 23601 | 0.150 |
Why?
|
Dextran Sulfate | 2 | 2017 | 255 | 0.150 |
Why?
|
Molecular Dynamics Simulation | 1 | 2021 | 431 | 0.150 |
Why?
|
Salmonella Infections | 1 | 2019 | 176 | 0.150 |
Why?
|
Upper Gastrointestinal Tract | 1 | 2018 | 46 | 0.150 |
Why?
|
Rats | 14 | 2017 | 23707 | 0.150 |
Why?
|
Malnutrition | 1 | 2024 | 629 | 0.150 |
Why?
|
Tryptophan | 1 | 2020 | 483 | 0.150 |
Why?
|
Gastroparesis | 1 | 2020 | 143 | 0.150 |
Why?
|
Bone Marrow | 2 | 2020 | 2921 | 0.150 |
Why?
|
Weightlessness | 2 | 2016 | 103 | 0.150 |
Why?
|
Disease Management | 2 | 2020 | 2535 | 0.140 |
Why?
|
Middle Aged | 29 | 2024 | 223009 | 0.140 |
Why?
|
Eating | 1 | 2024 | 1540 | 0.140 |
Why?
|
Pharmaceutical Preparations | 1 | 2006 | 1084 | 0.140 |
Why?
|
Dairy Products | 1 | 2021 | 491 | 0.140 |
Why?
|
Placenta | 3 | 2022 | 1728 | 0.140 |
Why?
|
Iron Overload | 1 | 2020 | 245 | 0.140 |
Why?
|
Genomics | 4 | 2023 | 5929 | 0.140 |
Why?
|
RNA, Messenger | 9 | 2024 | 12768 | 0.140 |
Why?
|
Bioreactors | 2 | 2016 | 244 | 0.140 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 2021 | 813 | 0.140 |
Why?
|
Liver | 1 | 2013 | 7562 | 0.140 |
Why?
|
Massachusetts | 3 | 2020 | 8875 | 0.140 |
Why?
|
Nephrotic Syndrome | 1 | 2021 | 380 | 0.140 |
Why?
|
Capsule Endoscopy | 1 | 2018 | 107 | 0.140 |
Why?
|
Gene Expression Regulation, Bacterial | 3 | 2019 | 1141 | 0.140 |
Why?
|
Severity of Illness Index | 8 | 2021 | 15880 | 0.140 |
Why?
|
Diagnostic Techniques, Digestive System | 2 | 2018 | 45 | 0.140 |
Why?
|
Duodenoscopy | 1 | 2017 | 45 | 0.140 |
Why?
|
Antigens, Viral | 1 | 2021 | 995 | 0.140 |
Why?
|
Incidence | 6 | 2022 | 21480 | 0.140 |
Why?
|
Microvilli | 3 | 2013 | 234 | 0.140 |
Why?
|
Ileitis | 1 | 2017 | 40 | 0.140 |
Why?
|
Double-Blind Method | 6 | 2022 | 12437 | 0.140 |
Why?
|
HMGA1a Protein | 1 | 2017 | 63 | 0.140 |
Why?
|
Infectious Disease Transmission, Vertical | 2 | 2021 | 1354 | 0.140 |
Why?
|
Cytomegalovirus | 1 | 2021 | 751 | 0.140 |
Why?
|
Vaccines, Attenuated | 2 | 2018 | 312 | 0.140 |
Why?
|
Paneth Cells | 1 | 2017 | 99 | 0.130 |
Why?
|
Cross-Sectional Studies | 8 | 2023 | 26318 | 0.130 |
Why?
|
Major Histocompatibility Complex | 1 | 2019 | 879 | 0.130 |
Why?
|
Stress, Psychological | 2 | 2023 | 4533 | 0.130 |
Why?
|
Peptide Fragments | 6 | 2015 | 5125 | 0.130 |
Why?
|
Genome-Wide Association Study | 3 | 2024 | 12807 | 0.130 |
Why?
|
Immunologic Factors | 3 | 2018 | 1587 | 0.130 |
Why?
|
Age Factors | 5 | 2020 | 18380 | 0.130 |
Why?
|
Models, Immunological | 1 | 2018 | 517 | 0.130 |
Why?
|
Polysaccharides, Bacterial | 1 | 2018 | 576 | 0.120 |
Why?
|
Up-Regulation | 4 | 2017 | 4137 | 0.120 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2020 | 1441 | 0.120 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 1 | 2017 | 305 | 0.120 |
Why?
|
Models, Biological | 4 | 2014 | 9443 | 0.120 |
Why?
|
N-Formylmethionine Leucyl-Phenylalanine | 1 | 2015 | 218 | 0.120 |
Why?
|
Endoscopy, Digestive System | 2 | 2018 | 358 | 0.120 |
Why?
|
Whole-Body Irradiation | 1 | 2016 | 438 | 0.120 |
Why?
|
Prenatal Diagnosis | 1 | 2022 | 1268 | 0.120 |
Why?
|
Practice Guidelines as Topic | 5 | 2012 | 7425 | 0.120 |
Why?
|
Spondylitis, Ankylosing | 1 | 2017 | 157 | 0.120 |
Why?
|
Sensitivity and Specificity | 6 | 2018 | 14652 | 0.120 |
Why?
|
Disease Models, Animal | 9 | 2021 | 18293 | 0.120 |
Why?
|
Chemotactic Factors | 1 | 2015 | 195 | 0.120 |
Why?
|
Phenotype | 6 | 2023 | 16721 | 0.120 |
Why?
|
Cells, Cultured | 10 | 2019 | 18973 | 0.120 |
Why?
|
Drug Delivery Systems | 1 | 2006 | 2207 | 0.120 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2021 | 1365 | 0.120 |
Why?
|
Anemia | 2 | 2015 | 1511 | 0.120 |
Why?
|
Th17 Cells | 2 | 2021 | 786 | 0.120 |
Why?
|
Duodenal Diseases | 1 | 2015 | 101 | 0.110 |
Why?
|
Vaccination | 6 | 2024 | 3426 | 0.110 |
Why?
|
Gene Expression | 4 | 2019 | 7584 | 0.110 |
Why?
|
Endothelium | 1 | 2017 | 767 | 0.110 |
Why?
|
Cohort Studies | 8 | 2023 | 41649 | 0.110 |
Why?
|
Infant, Very Low Birth Weight | 1 | 2017 | 410 | 0.110 |
Why?
|
Membrane Transport Proteins | 1 | 2019 | 1028 | 0.110 |
Why?
|
Body Weight | 3 | 2017 | 4622 | 0.110 |
Why?
|
Lymphocytosis | 1 | 2015 | 120 | 0.110 |
Why?
|
Macrophages | 3 | 2023 | 5772 | 0.110 |
Why?
|
Fetal Blood | 1 | 2020 | 1369 | 0.110 |
Why?
|
Cell Culture Techniques | 1 | 2021 | 1652 | 0.110 |
Why?
|
Receptors, Steroid | 1 | 2014 | 155 | 0.110 |
Why?
|
Behavior, Animal | 1 | 2021 | 1865 | 0.110 |
Why?
|
Enterocytes | 2 | 2021 | 220 | 0.110 |
Why?
|
Pediatrics | 3 | 2019 | 3606 | 0.110 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2020 | 3807 | 0.110 |
Why?
|
Histocompatibility Testing | 2 | 2007 | 726 | 0.110 |
Why?
|
Colony Count, Microbial | 1 | 2014 | 326 | 0.110 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2016 | 636 | 0.110 |
Why?
|
Electric Impedance | 3 | 2013 | 794 | 0.100 |
Why?
|
Aged | 16 | 2024 | 171117 | 0.100 |
Why?
|
Neutrophil Infiltration | 1 | 2015 | 394 | 0.100 |
Why?
|
Drug Discovery | 1 | 2021 | 1064 | 0.100 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3100 | 0.100 |
Why?
|
Binding Sites | 1 | 2021 | 6001 | 0.100 |
Why?
|
Sex Distribution | 2 | 2016 | 2263 | 0.100 |
Why?
|
Chemotaxis, Leukocyte | 1 | 2015 | 657 | 0.100 |
Why?
|
Ileum | 4 | 2017 | 558 | 0.100 |
Why?
|
Receptor, Cannabinoid, CB1 | 1 | 2013 | 138 | 0.100 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3223 | 0.100 |
Why?
|
Asia | 1 | 2014 | 628 | 0.100 |
Why?
|
Delayed Diagnosis | 1 | 2016 | 452 | 0.100 |
Why?
|
Radiation Protection | 1 | 2016 | 424 | 0.100 |
Why?
|
Treatment Outcome | 8 | 2024 | 65188 | 0.100 |
Why?
|
Jejunum | 2 | 2012 | 474 | 0.100 |
Why?
|
Cell Communication | 1 | 2019 | 1660 | 0.100 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2020 | 10729 | 0.100 |
Why?
|
Switzerland | 3 | 2018 | 322 | 0.100 |
Why?
|
Dendritic Cells | 3 | 2020 | 2747 | 0.100 |
Why?
|
Protein Isoforms | 1 | 2017 | 1718 | 0.100 |
Why?
|
Calcium-Binding Proteins | 1 | 2016 | 1077 | 0.100 |
Why?
|
Longevity | 1 | 2019 | 1087 | 0.100 |
Why?
|
Carrier Proteins | 2 | 2022 | 4913 | 0.100 |
Why?
|
Infant Food | 1 | 2012 | 139 | 0.090 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2016 | 4058 | 0.090 |
Why?
|
T-Lymphocytes | 3 | 2023 | 10261 | 0.090 |
Why?
|
Immune Tolerance | 2 | 2016 | 2324 | 0.090 |
Why?
|
Brain | 2 | 2017 | 27171 | 0.090 |
Why?
|
Microfilament Proteins | 1 | 2016 | 1130 | 0.090 |
Why?
|
Lymphocytes | 4 | 2019 | 2599 | 0.090 |
Why?
|
Postmenopause | 1 | 2020 | 2515 | 0.090 |
Why?
|
Antigens, Plant | 1 | 2011 | 103 | 0.090 |
Why?
|
Leukocytes | 1 | 2019 | 2027 | 0.090 |
Why?
|
Patient Participation | 1 | 2020 | 1455 | 0.090 |
Why?
|
Reproducibility of Results | 4 | 2020 | 20124 | 0.090 |
Why?
|
Enterotoxins | 1 | 2012 | 366 | 0.090 |
Why?
|
Endometrial Neoplasms | 1 | 2020 | 1378 | 0.090 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2024 | 4642 | 0.090 |
Why?
|
Weight Loss | 2 | 2020 | 2710 | 0.090 |
Why?
|
Anti-Inflammatory Agents | 1 | 2020 | 1808 | 0.090 |
Why?
|
Pandemics | 5 | 2021 | 8703 | 0.090 |
Why?
|
Bioengineering | 1 | 2011 | 97 | 0.090 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2015 | 844 | 0.090 |
Why?
|
Protein Kinase C-alpha | 1 | 2010 | 112 | 0.090 |
Why?
|
Primary Health Care | 1 | 2007 | 4736 | 0.090 |
Why?
|
Glomerular Filtration Rate | 1 | 2019 | 2233 | 0.090 |
Why?
|
Metabolic Diseases | 1 | 2016 | 687 | 0.080 |
Why?
|
Regeneration | 2 | 2016 | 1517 | 0.080 |
Why?
|
Weight Gain | 1 | 2020 | 2355 | 0.080 |
Why?
|
Immune System Diseases | 1 | 2012 | 251 | 0.080 |
Why?
|
Complement System Proteins | 1 | 2013 | 715 | 0.080 |
Why?
|
Cholestasis | 1 | 2013 | 386 | 0.080 |
Why?
|
Hordeum | 1 | 2009 | 18 | 0.080 |
Why?
|
Threonine | 1 | 2010 | 272 | 0.080 |
Why?
|
Public Health | 1 | 2003 | 2680 | 0.080 |
Why?
|
Lactation | 2 | 2022 | 391 | 0.080 |
Why?
|
Atrophy | 2 | 2013 | 1635 | 0.080 |
Why?
|
Receptors, CCR6 | 1 | 2009 | 73 | 0.080 |
Why?
|
Age of Onset | 3 | 2021 | 3344 | 0.080 |
Why?
|
Musculoskeletal Diseases | 1 | 2015 | 598 | 0.080 |
Why?
|
Myeloid Differentiation Factor 88 | 3 | 2008 | 582 | 0.080 |
Why?
|
Acute Lung Injury | 1 | 2013 | 377 | 0.080 |
Why?
|
Dietary Proteins | 1 | 2014 | 959 | 0.080 |
Why?
|
Kaplan-Meier Estimate | 2 | 2017 | 6499 | 0.080 |
Why?
|
Immunoblotting | 2 | 2010 | 1644 | 0.080 |
Why?
|
Caspases | 1 | 2012 | 880 | 0.080 |
Why?
|
Interleukin-15 | 1 | 2010 | 186 | 0.080 |
Why?
|
Phylogeny | 2 | 2018 | 2832 | 0.080 |
Why?
|
Sweden | 1 | 2012 | 1381 | 0.080 |
Why?
|
Bone Diseases, Metabolic | 1 | 2012 | 407 | 0.080 |
Why?
|
Alleles | 1 | 2020 | 6897 | 0.080 |
Why?
|
Sulfonamides | 1 | 2018 | 1984 | 0.080 |
Why?
|
Cross-Over Studies | 1 | 2015 | 2108 | 0.080 |
Why?
|
Italy | 3 | 2019 | 854 | 0.080 |
Why?
|
Principal Component Analysis | 1 | 2012 | 951 | 0.080 |
Why?
|
Acute Disease | 4 | 2023 | 7232 | 0.080 |
Why?
|
Gas Chromatography-Mass Spectrometry | 1 | 2009 | 355 | 0.080 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2015 | 1657 | 0.080 |
Why?
|
Time Factors | 5 | 2022 | 40065 | 0.080 |
Why?
|
Rats, Wistar | 2 | 2010 | 1884 | 0.080 |
Why?
|
Retrospective Studies | 7 | 2022 | 81514 | 0.070 |
Why?
|
Nutritional Support | 1 | 2020 | 178 | 0.070 |
Why?
|
Nutritional Physiological Phenomena | 1 | 2020 | 357 | 0.070 |
Why?
|
Aged, 80 and over | 7 | 2024 | 59489 | 0.070 |
Why?
|
Cell Proliferation | 4 | 2019 | 10429 | 0.070 |
Why?
|
Mental Health | 1 | 2022 | 3278 | 0.070 |
Why?
|
Antigens | 1 | 2013 | 1438 | 0.070 |
Why?
|
Genetic Loci | 2 | 2014 | 2631 | 0.070 |
Why?
|
Receptors, Proteinase-Activated | 1 | 2007 | 18 | 0.070 |
Why?
|
Drug Administration Routes | 1 | 2007 | 152 | 0.070 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 2009 | 353 | 0.070 |
Why?
|
Chronic Disease | 2 | 2019 | 9347 | 0.070 |
Why?
|
Europe | 1 | 2014 | 3423 | 0.070 |
Why?
|
Follow-Up Studies | 5 | 2020 | 39193 | 0.070 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 2021 | 3111 | 0.070 |
Why?
|
Adjuvants, Immunologic | 2 | 2003 | 995 | 0.070 |
Why?
|
Bacterial Proteins | 2 | 2019 | 3837 | 0.070 |
Why?
|
Mice, Inbred BALB C | 4 | 2010 | 6220 | 0.070 |
Why?
|
Cell Survival | 3 | 2014 | 5747 | 0.070 |
Why?
|
Age Distribution | 2 | 2010 | 2858 | 0.070 |
Why?
|
Interleukin-23 | 1 | 2008 | 202 | 0.070 |
Why?
|
Skin Diseases | 1 | 2015 | 1088 | 0.070 |
Why?
|
Eosinophilic Esophagitis | 1 | 2020 | 206 | 0.070 |
Why?
|
Serine | 1 | 2010 | 824 | 0.070 |
Why?
|
Algorithms | 4 | 2014 | 14071 | 0.070 |
Why?
|
Bacteremia | 1 | 2013 | 989 | 0.060 |
Why?
|
ROC Curve | 1 | 2014 | 3620 | 0.060 |
Why?
|
Artificial Intelligence | 1 | 2021 | 2659 | 0.060 |
Why?
|
Early Detection of Cancer | 1 | 2020 | 3236 | 0.060 |
Why?
|
RNA Interference | 2 | 2014 | 2832 | 0.060 |
Why?
|
Nutritional Status | 2 | 2024 | 1620 | 0.060 |
Why?
|
Inflammation Mediators | 3 | 2021 | 1884 | 0.060 |
Why?
|
Arthritis, Rheumatoid | 1 | 2021 | 3733 | 0.060 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2009 | 1526 | 0.060 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 2 | 2021 | 537 | 0.060 |
Why?
|
United States | 7 | 2022 | 72903 | 0.060 |
Why?
|
Prognosis | 3 | 2020 | 29922 | 0.060 |
Why?
|
Rats, Inbred BB | 1 | 2005 | 29 | 0.060 |
Why?
|
Societies, Medical | 4 | 2013 | 3956 | 0.060 |
Why?
|
Adherens Junctions | 2 | 2017 | 89 | 0.060 |
Why?
|
Constipation | 2 | 2022 | 568 | 0.060 |
Why?
|
Fibroblasts | 2 | 2016 | 4159 | 0.060 |
Why?
|
Child Nutritional Physiological Phenomena | 2 | 2004 | 292 | 0.060 |
Why?
|
Tomography, Optical Coherence | 1 | 2018 | 2932 | 0.060 |
Why?
|
Lactoferrin | 1 | 2005 | 99 | 0.060 |
Why?
|
Antibodies, Bacterial | 2 | 2018 | 1476 | 0.060 |
Why?
|
Physicians, Family | 1 | 2007 | 349 | 0.060 |
Why?
|
Mice, Mutant Strains | 1 | 2008 | 1745 | 0.060 |
Why?
|
Th1 Cells | 1 | 2010 | 1039 | 0.060 |
Why?
|
Cyclosporine | 1 | 2007 | 778 | 0.060 |
Why?
|
Nervous System Diseases | 1 | 2015 | 1660 | 0.060 |
Why?
|
Interleukin-1 | 1 | 2008 | 1243 | 0.060 |
Why?
|
Biological Availability | 4 | 2007 | 385 | 0.060 |
Why?
|
Lymphocyte Count | 1 | 2007 | 790 | 0.060 |
Why?
|
Anorexia | 1 | 2005 | 153 | 0.060 |
Why?
|
Early Diagnosis | 1 | 2009 | 1187 | 0.060 |
Why?
|
Dietary Supplements | 2 | 2024 | 3425 | 0.060 |
Why?
|
Feasibility Studies | 3 | 2021 | 5302 | 0.060 |
Why?
|
Heparin, Low-Molecular-Weight | 1 | 2006 | 345 | 0.060 |
Why?
|
Bayes Theorem | 2 | 2022 | 2354 | 0.060 |
Why?
|
Fluid Therapy | 2 | 2005 | 584 | 0.060 |
Why?
|
Nose | 1 | 2007 | 519 | 0.060 |
Why?
|
Mental Disorders | 2 | 2015 | 6853 | 0.050 |
Why?
|
Acyclovir | 1 | 2004 | 267 | 0.050 |
Why?
|
RNA, Viral | 2 | 2023 | 2864 | 0.050 |
Why?
|
Microscopy, Fluorescence | 2 | 2012 | 2627 | 0.050 |
Why?
|
North America | 1 | 2007 | 1285 | 0.050 |
Why?
|
Vitamin D Deficiency | 1 | 2012 | 1348 | 0.050 |
Why?
|
Referral and Consultation | 1 | 2016 | 3615 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2017 | 10383 | 0.050 |
Why?
|
Mitoxantrone | 1 | 2022 | 148 | 0.050 |
Why?
|
Mutation, Missense | 1 | 2012 | 2589 | 0.050 |
Why?
|
Tetanus Toxoid | 1 | 2003 | 188 | 0.050 |
Why?
|
Anthrax | 1 | 2003 | 83 | 0.050 |
Why?
|
Rats, Sprague-Dawley | 7 | 2007 | 8102 | 0.050 |
Why?
|
Gastroesophageal Reflux | 1 | 2020 | 833 | 0.050 |
Why?
|
Mannitol | 1 | 2003 | 176 | 0.050 |
Why?
|
Gallbladder | 1 | 2024 | 308 | 0.050 |
Why?
|
Stroke | 1 | 2024 | 9747 | 0.050 |
Why?
|
Fatty Acids, Volatile | 1 | 2023 | 100 | 0.050 |
Why?
|
Vaccines, Synthetic | 1 | 2024 | 621 | 0.050 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2012 | 3672 | 0.050 |
Why?
|
Recombinant Proteins | 2 | 2009 | 6493 | 0.050 |
Why?
|
Finland | 1 | 2003 | 608 | 0.050 |
Why?
|
Salmonella | 1 | 2022 | 122 | 0.050 |
Why?
|
Bacterial Physiological Phenomena | 1 | 2002 | 119 | 0.050 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2019 | 4348 | 0.050 |
Why?
|
Macromolecular Substances | 1 | 2004 | 1430 | 0.050 |
Why?
|
Gangliosides | 1 | 2002 | 132 | 0.050 |
Why?
|
Escherichia coli Infections | 1 | 2005 | 519 | 0.050 |
Why?
|
Digestive System | 1 | 2002 | 244 | 0.050 |
Why?
|
Protein Biosynthesis | 1 | 2008 | 2086 | 0.050 |
Why?
|
Analysis of Variance | 3 | 2017 | 6203 | 0.050 |
Why?
|
Staphylococcus aureus | 1 | 2009 | 1424 | 0.050 |
Why?
|
Bone Development | 1 | 2004 | 468 | 0.050 |
Why?
|
Adipose Tissue | 1 | 2013 | 3312 | 0.050 |
Why?
|
Polymerase Chain Reaction | 2 | 2012 | 6069 | 0.050 |
Why?
|
Drug Carriers | 1 | 2005 | 700 | 0.050 |
Why?
|
Mucus | 1 | 2023 | 346 | 0.050 |
Why?
|
Neoplasms | 3 | 2022 | 22340 | 0.040 |
Why?
|
Neutrophil Activation | 1 | 2021 | 180 | 0.040 |
Why?
|
Genotype | 3 | 2014 | 13024 | 0.040 |
Why?
|
Methane | 1 | 2020 | 44 | 0.040 |
Why?
|
Thioctic Acid | 1 | 2020 | 28 | 0.040 |
Why?
|
Blotting, Western | 3 | 2012 | 5020 | 0.040 |
Why?
|
Clinical Competence | 1 | 2016 | 4863 | 0.040 |
Why?
|
Transfection | 1 | 2008 | 5743 | 0.040 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2024 | 4405 | 0.040 |
Why?
|
Asymptomatic Infections | 1 | 2021 | 136 | 0.040 |
Why?
|
Bariatric Surgery | 1 | 2020 | 997 | 0.040 |
Why?
|
Bangladesh | 1 | 2022 | 745 | 0.040 |
Why?
|
HEK293 Cells | 2 | 2022 | 4260 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2022 | 13648 | 0.040 |
Why?
|
Muscle Fibers, Skeletal | 1 | 2003 | 552 | 0.040 |
Why?
|
Mucins | 1 | 2023 | 567 | 0.040 |
Why?
|
Immobilization | 1 | 2020 | 225 | 0.040 |
Why?
|
Arginase | 1 | 2020 | 81 | 0.040 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2012 | 2531 | 0.040 |
Why?
|
Cadherins | 2 | 2017 | 900 | 0.040 |
Why?
|
Endoscopy | 1 | 2009 | 1841 | 0.040 |
Why?
|
Colitis, Ulcerative | 1 | 2011 | 1915 | 0.040 |
Why?
|
Immunity, Humoral | 1 | 2024 | 605 | 0.040 |
Why?
|
Phosphorylation | 1 | 2010 | 8278 | 0.040 |
Why?
|
DNA-Binding Proteins | 1 | 2016 | 9601 | 0.040 |
Why?
|
Logistic Models | 3 | 2016 | 13266 | 0.040 |
Why?
|
Chi-Square Distribution | 2 | 2018 | 3432 | 0.040 |
Why?
|
Immunoglobulin M | 2 | 2020 | 1528 | 0.040 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2008 | 2900 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 4 | 2024 | 16047 | 0.040 |
Why?
|
Receptors, Fc | 1 | 2022 | 536 | 0.040 |
Why?
|
Crohn Disease | 1 | 2011 | 2283 | 0.040 |
Why?
|
HT29 Cells | 1 | 2019 | 187 | 0.040 |
Why?
|
Escherichia coli Proteins | 1 | 2005 | 1057 | 0.040 |
Why?
|
Diagnostic Errors | 2 | 2018 | 1275 | 0.040 |
Why?
|
Administration, Intranasal | 3 | 2007 | 482 | 0.040 |
Why?
|
Virulence Factors | 2 | 2016 | 500 | 0.040 |
Why?
|
Receptors, Antigen, B-Cell | 1 | 2021 | 545 | 0.040 |
Why?
|
Interferon Regulatory Factors | 1 | 2020 | 271 | 0.040 |
Why?
|
Proteomics | 2 | 2022 | 3910 | 0.040 |
Why?
|
Protein Binding | 1 | 2010 | 9296 | 0.040 |
Why?
|
Symbiosis | 1 | 2020 | 297 | 0.040 |
Why?
|
Models, Statistical | 1 | 2012 | 5089 | 0.040 |
Why?
|
Disease Progression | 2 | 2023 | 13632 | 0.040 |
Why?
|
Perinatal Care | 1 | 2020 | 246 | 0.040 |
Why?
|
Macaca mulatta | 3 | 2016 | 2341 | 0.040 |
Why?
|
Quality of Life | 1 | 2019 | 13462 | 0.040 |
Why?
|
Virulence | 1 | 2021 | 1289 | 0.040 |
Why?
|
Desulfovibrio | 1 | 2017 | 7 | 0.040 |
Why?
|
Rhamnose | 1 | 2017 | 17 | 0.040 |
Why?
|
Salmonella typhimurium | 1 | 2019 | 348 | 0.040 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 2 | 2024 | 3719 | 0.040 |
Why?
|
Plasma | 1 | 2020 | 579 | 0.030 |
Why?
|
Administration, Oral | 4 | 2007 | 4015 | 0.030 |
Why?
|
Folic Acid | 1 | 2024 | 1338 | 0.030 |
Why?
|
Carrier State | 1 | 2021 | 529 | 0.030 |
Why?
|
Rabbits | 3 | 2012 | 4734 | 0.030 |
Why?
|
Influenza A virus | 1 | 2020 | 453 | 0.030 |
Why?
|
Rats, Transgenic | 1 | 2017 | 70 | 0.030 |
Why?
|
Health Policy | 1 | 2009 | 2698 | 0.030 |
Why?
|
HLA-B27 Antigen | 1 | 2017 | 66 | 0.030 |
Why?
|
Lactose | 1 | 2017 | 95 | 0.030 |
Why?
|
Vaccines | 1 | 2005 | 841 | 0.030 |
Why?
|
Prevotella | 1 | 2017 | 81 | 0.030 |
Why?
|
Cardiovascular Diseases | 2 | 2019 | 15652 | 0.030 |
Why?
|
Metabolic Networks and Pathways | 1 | 2021 | 798 | 0.030 |
Why?
|
Toll-Like Receptor 2 | 2 | 2011 | 348 | 0.030 |
Why?
|
Autonomic Nervous System | 1 | 2021 | 706 | 0.030 |
Why?
|
Epithelium | 1 | 2021 | 1599 | 0.030 |
Why?
|
Emergency Service, Hospital | 1 | 2016 | 7875 | 0.030 |
Why?
|
Cost-Benefit Analysis | 1 | 2009 | 5526 | 0.030 |
Why?
|
SOX9 Transcription Factor | 1 | 2017 | 146 | 0.030 |
Why?
|
Quantitative Trait Loci | 1 | 2024 | 2140 | 0.030 |
Why?
|
Avitaminosis | 1 | 2016 | 35 | 0.030 |
Why?
|
Diet Surveys | 1 | 2020 | 1159 | 0.030 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2002 | 712 | 0.030 |
Why?
|
Biological Transport | 3 | 2007 | 2081 | 0.030 |
Why?
|
Absorption | 2 | 2007 | 242 | 0.030 |
Why?
|
Time-Lapse Imaging | 1 | 2017 | 195 | 0.030 |
Why?
|
Chromosome Aberrations | 1 | 2022 | 1774 | 0.030 |
Why?
|
Phospholipids | 1 | 2019 | 776 | 0.030 |
Why?
|
Acute-Phase Proteins | 1 | 2017 | 252 | 0.030 |
Why?
|
Genetic Markers | 2 | 2012 | 2601 | 0.030 |
Why?
|
Infant Formula | 1 | 2017 | 192 | 0.030 |
Why?
|
Activities of Daily Living | 1 | 2024 | 2415 | 0.030 |
Why?
|
Vasculitis | 1 | 2019 | 527 | 0.030 |
Why?
|
Family | 1 | 2006 | 3209 | 0.030 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2017 | 291 | 0.030 |
Why?
|
Family Health | 2 | 2012 | 1253 | 0.030 |
Why?
|
Fetal Development | 1 | 2020 | 777 | 0.030 |
Why?
|
Gene Expression Profiling | 1 | 2011 | 9525 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 4562 | 0.030 |
Why?
|
Dogs | 1 | 2019 | 3822 | 0.030 |
Why?
|
Immunosuppressive Agents | 1 | 2007 | 4209 | 0.030 |
Why?
|
Americas | 1 | 2014 | 109 | 0.030 |
Why?
|
Clinical Trials as Topic | 2 | 2013 | 8041 | 0.030 |
Why?
|
Enteral Nutrition | 1 | 2020 | 803 | 0.030 |
Why?
|
Indomethacin | 1 | 2014 | 322 | 0.030 |
Why?
|
Infant, Premature | 1 | 2023 | 2122 | 0.030 |
Why?
|
Medical Records | 1 | 2019 | 1409 | 0.030 |
Why?
|
Stem Cell Niche | 1 | 2017 | 346 | 0.030 |
Why?
|
Antigens, CD | 2 | 2017 | 4025 | 0.030 |
Why?
|
HeLa Cells | 1 | 2019 | 3067 | 0.030 |
Why?
|
Risk Assessment | 3 | 2012 | 24282 | 0.030 |
Why?
|
Bacteriophages | 1 | 2017 | 381 | 0.030 |
Why?
|
Colitis, Microscopic | 1 | 2014 | 72 | 0.030 |
Why?
|
Mice, Inbred A | 1 | 2013 | 244 | 0.030 |
Why?
|
DNA | 1 | 2007 | 7202 | 0.030 |
Why?
|
Bread | 1 | 2012 | 23 | 0.030 |
Why?
|
RNA, Small Interfering | 2 | 2014 | 3421 | 0.030 |
Why?
|
Myeloid Cells | 1 | 2018 | 839 | 0.030 |
Why?
|
Flour | 1 | 2012 | 22 | 0.030 |
Why?
|
Congo Red | 1 | 2012 | 49 | 0.030 |
Why?
|
Movement | 1 | 2019 | 1462 | 0.030 |
Why?
|
Shigella | 1 | 2013 | 69 | 0.030 |
Why?
|
Area Under Curve | 2 | 2007 | 1638 | 0.020 |
Why?
|
Bone Marrow Cells | 1 | 2020 | 2412 | 0.020 |
Why?
|
Esophagus | 1 | 2018 | 1037 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2020 | 4850 | 0.020 |
Why?
|
Drug Interactions | 2 | 2007 | 1417 | 0.020 |
Why?
|
Body Mass Index | 1 | 2010 | 13039 | 0.020 |
Why?
|
Reference Values | 2 | 2012 | 4908 | 0.020 |
Why?
|
Sucrase-Isomaltase Complex | 1 | 2011 | 12 | 0.020 |
Why?
|
Anemia, Iron-Deficiency | 1 | 2016 | 374 | 0.020 |
Why?
|
Multivariate Analysis | 2 | 2016 | 12056 | 0.020 |
Why?
|
Cesarean Section | 1 | 2020 | 1431 | 0.020 |
Why?
|
Spain | 1 | 2012 | 483 | 0.020 |
Why?
|
Risk | 2 | 2014 | 9591 | 0.020 |
Why?
|
Norway | 1 | 2012 | 499 | 0.020 |
Why?
|
Plasmids | 1 | 2016 | 2274 | 0.020 |
Why?
|
Sodium-Glucose Transporter 1 | 1 | 2011 | 108 | 0.020 |
Why?
|
Antigen-Antibody Complex | 1 | 2013 | 508 | 0.020 |
Why?
|
Integrin alpha Chains | 1 | 2011 | 93 | 0.020 |
Why?
|
Complement Activation | 1 | 2013 | 431 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2017 | 1966 | 0.020 |
Why?
|
Obsessive-Compulsive Disorder | 1 | 2020 | 1484 | 0.020 |
Why?
|
Antibodies, Neutralizing | 1 | 2021 | 2010 | 0.020 |
Why?
|
Endothelium, Vascular | 1 | 2003 | 4427 | 0.020 |
Why?
|
Child Health Services | 1 | 2016 | 645 | 0.020 |
Why?
|
Neoplasm Proteins | 1 | 2022 | 3596 | 0.020 |
Why?
|
Neurodegenerative Diseases | 1 | 2019 | 1087 | 0.020 |
Why?
|
Hematopoiesis | 1 | 2020 | 2058 | 0.020 |
Why?
|
Germany | 1 | 2012 | 882 | 0.020 |
Why?
|
Schools | 1 | 2019 | 1492 | 0.020 |
Why?
|
Trans-Activators | 1 | 2020 | 2850 | 0.020 |
Why?
|
Unnecessary Procedures | 1 | 2014 | 416 | 0.020 |
Why?
|
DNA, Viral | 1 | 2017 | 2199 | 0.020 |
Why?
|
Ataxia | 1 | 2012 | 307 | 0.020 |
Why?
|
Ki-67 Antigen | 1 | 2011 | 629 | 0.020 |
Why?
|
Asymptomatic Diseases | 1 | 2012 | 586 | 0.020 |
Why?
|
Research Support as Topic | 1 | 2013 | 696 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2011 | 1701 | 0.020 |
Why?
|
Patient Selection | 1 | 2020 | 4255 | 0.020 |
Why?
|
DNA Primers | 1 | 2012 | 2825 | 0.020 |
Why?
|
Linear Models | 1 | 2018 | 5876 | 0.020 |
Why?
|
History, 21st Century | 1 | 2014 | 1574 | 0.020 |
Why?
|
Life Style | 1 | 2019 | 3926 | 0.020 |
Why?
|
Inulin | 1 | 2007 | 67 | 0.020 |
Why?
|
Collagen Type I | 1 | 2011 | 615 | 0.020 |
Why?
|
Gestational Age | 1 | 2017 | 3609 | 0.020 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2012 | 1167 | 0.020 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2022 | 5337 | 0.020 |
Why?
|
Reperfusion Injury | 1 | 2014 | 1042 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2020 | 4520 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2019 | 3564 | 0.020 |
Why?
|
Macrophages, Peritoneal | 1 | 2008 | 243 | 0.020 |
Why?
|
Receptors, Interleukin | 1 | 2008 | 243 | 0.020 |
Why?
|
Biomedical Research | 2 | 2013 | 3458 | 0.020 |
Why?
|
Linkage Disequilibrium | 1 | 2012 | 1997 | 0.020 |
Why?
|
Immunoglobulin E | 1 | 2013 | 1481 | 0.020 |
Why?
|
Trachea | 1 | 2013 | 1085 | 0.020 |
Why?
|
Chemistry, Pharmaceutical | 1 | 2007 | 272 | 0.020 |
Why?
|
Adaptor Proteins, Vesicular Transport | 1 | 2008 | 298 | 0.020 |
Why?
|
HLA-D Antigens | 1 | 2006 | 130 | 0.020 |
Why?
|
History, 20th Century | 1 | 2014 | 2761 | 0.020 |
Why?
|
Indoles | 1 | 2014 | 1839 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2022 | 17075 | 0.020 |
Why?
|
Membrane Glycoproteins | 1 | 2017 | 3690 | 0.020 |
Why?
|
Agglutination Tests | 1 | 2005 | 43 | 0.020 |
Why?
|
CD4 Lymphocyte Count | 1 | 2012 | 2587 | 0.020 |
Why?
|
Developing Countries | 2 | 2013 | 2911 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2016 | 2780 | 0.020 |
Why?
|
Lymphocyte Activation | 2 | 2010 | 5501 | 0.020 |
Why?
|
Genes, Dominant | 1 | 2008 | 856 | 0.020 |
Why?
|
Fermentation | 1 | 2005 | 141 | 0.020 |
Why?
|
Protein Kinase C | 1 | 2010 | 1202 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2016 | 5786 | 0.020 |
Why?
|
Paris | 1 | 2004 | 40 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2005 | 11868 | 0.010 |
Why?
|
Drug Compounding | 1 | 2005 | 235 | 0.010 |
Why?
|
Hydrolysis | 1 | 2005 | 642 | 0.010 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2014 | 2268 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2016 | 3685 | 0.010 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2017 | 3655 | 0.010 |
Why?
|
Muscles | 1 | 2009 | 1578 | 0.010 |
Why?
|
Cell Separation | 1 | 2010 | 1718 | 0.010 |
Why?
|
Hygiene | 1 | 2004 | 95 | 0.010 |
Why?
|
K562 Cells | 1 | 2005 | 649 | 0.010 |
Why?
|
Decision Support Techniques | 1 | 2014 | 2003 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2011 | 6113 | 0.010 |
Why?
|
Clostridium tetani | 1 | 2003 | 5 | 0.010 |
Why?
|
Colon | 1 | 2011 | 1795 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2012 | 4108 | 0.010 |
Why?
|
Extracellular Matrix | 1 | 2011 | 1727 | 0.010 |
Why?
|
Gene Silencing | 1 | 2010 | 1505 | 0.010 |
Why?
|
Administration, Rectal | 1 | 2003 | 69 | 0.010 |
Why?
|
Rhodamine 123 | 1 | 2003 | 37 | 0.010 |
Why?
|
Boston | 1 | 2016 | 9338 | 0.010 |
Why?
|
Tetanus Toxin | 1 | 2003 | 46 | 0.010 |
Why?
|
Tetanus | 1 | 2003 | 52 | 0.010 |
Why?
|
Fluorescent Antibody Technique, Direct | 1 | 2002 | 67 | 0.010 |
Why?
|
Biological Transport, Active | 1 | 2003 | 323 | 0.010 |
Why?
|
Cricetinae | 1 | 2006 | 2411 | 0.010 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2012 | 6014 | 0.010 |
Why?
|
New York City | 1 | 2004 | 733 | 0.010 |
Why?
|
Polyethylene Glycols | 1 | 2007 | 1188 | 0.010 |
Why?
|
Tissue Distribution | 1 | 2005 | 2266 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2019 | 5891 | 0.010 |
Why?
|
Ovalbumin | 1 | 2003 | 674 | 0.010 |
Why?
|
Molecular Weight | 1 | 2003 | 2163 | 0.010 |
Why?
|
Hospitalization | 1 | 2020 | 10808 | 0.010 |
Why?
|
Cell Membrane | 1 | 2010 | 3634 | 0.010 |
Why?
|
Lymph Nodes | 1 | 2011 | 3454 | 0.010 |
Why?
|
NF-kappa B | 1 | 2008 | 2485 | 0.010 |
Why?
|
Odds Ratio | 1 | 2012 | 9649 | 0.010 |
Why?
|
Homozygote | 1 | 2004 | 1775 | 0.010 |
Why?
|
Probability | 1 | 2005 | 2475 | 0.010 |
Why?
|
Capillaries | 1 | 2003 | 755 | 0.010 |
Why?
|
Recurrence | 1 | 2012 | 8501 | 0.010 |
Why?
|
Mitosis | 1 | 2004 | 1173 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2010 | 5881 | 0.010 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2004 | 1333 | 0.010 |
Why?
|
Methotrexate | 1 | 2005 | 1722 | 0.010 |
Why?
|
Developed Countries | 1 | 2002 | 452 | 0.010 |
Why?
|
Immunization | 1 | 2003 | 1219 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2012 | 11022 | 0.010 |
Why?
|
Cyclic AMP | 1 | 2002 | 1467 | 0.010 |
Why?
|
Actins | 1 | 2005 | 2056 | 0.010 |
Why?
|
Paclitaxel | 1 | 2005 | 1728 | 0.010 |
Why?
|
Epilepsy | 1 | 2012 | 3320 | 0.010 |
Why?
|
Apoptosis | 1 | 2012 | 9514 | 0.010 |
Why?
|
Antipsychotic Agents | 1 | 2009 | 3076 | 0.010 |
Why?
|
Research | 1 | 2004 | 1975 | 0.010 |
Why?
|
Fluorescent Dyes | 1 | 2003 | 1930 | 0.010 |
Why?
|
Lung | 1 | 2013 | 10033 | 0.010 |
Why?
|
Primary Prevention | 1 | 2002 | 1187 | 0.010 |
Why?
|
Energy Metabolism | 1 | 2004 | 2892 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2008 | 14448 | 0.010 |
Why?
|
Health Promotion | 1 | 2004 | 2208 | 0.010 |
Why?
|
Calcium | 1 | 2002 | 5767 | 0.000 |
Why?
|